Endoscopic Relapse Risks Evaluation After Ileocolic Resection for Crohn's Disease
Conditions: Crohn ' s Disease Interventions: Procedure: Ileocolic resection Sponsors: University Hospital, Montpellier; Car émeau University Hospital, Nîmes Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials
PRecisiOn Microbiome Directed ExtensiOn of Anti-TNF α Crohn's Disease ThErapy in Children: The PROMOTE Trial
Conditions: Inflammatory Bowel Diseases; Crohn Disease Interventions: Other: Resistant Starch; Other: Placebo Sponsors: Children ' s Hospital of Eastern Ontario Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials
Bowel Preparation for Colonoscopy Among Individuals With Crohn's and Ulcerative Colitis Disease.
Conditions: Crohn Disease; Ulcerative Colitis Interventions: Drug: KleanLyte; Drug: Bi-PegLyte Sponsors: University of Manitoba; Canadian IBD Research Consortium (CIRC) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials
Risankizumab in Children With Crohn's Disease (RisaKids)
Conditions: Crohn Disease Interventions: Drug: Risankizumab Sponsors: Shaare Zedek Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials
Testing the Role for Anti-fungal Therapy in Improving the Response to Medicine for Crohn's Disease
Conditions: Crohn ' s Disease; Inflammatory Bowel Diseases Interventions: Drug: Fluconazole; Drug: Placebo; Biological: IL-23 Therapy Sponsors: Weill Medical College of Cornell University; The Leona M. and Harry B. Helmsley Charitable Trust Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
Conditions: Moderately to Severely Active Crohn ' s Disease; Crohn Disease; Disease Crohn Interventions: Biological: Vedolizumab Sponsors: Alimentiv Inc.; Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials
Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.
Conditions: Crohn Disease Interventions: Drug: Radiotracer Injection; Drug: Contrast Media, Magnetic Resonance; Diagnostic Test: Blood Draw; Drug: Glucagon; Diagnostic Test: Imaging; Drug: Oral contrast media application Sponsors: Massachusetts General Hospital; Takeda Development Center Americas, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials
Identification of Factors ASsociaTed With a Delayed Diagnosis in Crohn's Disease
Conditions: Crohn Disease Interventions: Other: Questionnaire completion Sponsors: Groupe d ' Etude Therapeutique des Affections Inflammatoires Digestives Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials
Effects of Gluten Free Diet in Ulcerative Colitis
Conditions: Inflammatory Bowel Diseases; Ulcerative Colitis Interventions: Dietary Supplement: High gluten diet; Dietary Supplement: Gluten free diet Sponsors: University of Southern Denmark; Odense University Hospital; Colitis-Crohn Foreningen; Hospital of Southern Jutland; University Hospital Bispebjerg and Frederiksberg Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
VOICE-Early Response to Vedolizumab and Ustekinumab in Participants With Crohn's Disease: A Prospective Observational Study
Conditions: Crohn ' s Disease Interventions: Drug: Vedolizumab (VDZ); Drug: Ustekinumab (UST) Sponsors: Alimentiv Inc.; Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
TOward a Better Understanding of the autoPhagy Machinery for the Identification of Potential Novel Biomarkers and Therapeutic Targets in Crohn's Disease - TOPIC Study
Conditions: Crohn ' s Disease Interventions: Biological: Blood samples; Biological: Stool simple; Biological: Ileocolonic biopsies Sponsors: Hospices Civils de Lyon; Centre International de Recherche en Infectiologie (CIRI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials
Comparing Surgical Approaches for Crohn's Disease Recurrence
Conditions: Endoscopic Recurrence Rate; After Ileocolic Crohn ' s Disease Surgery Interventions: Procedure: mesentery-guided resection margin Sponsors: Sixth Affiliated Hospital, Sun Yat-sen University; First Affiliated Hospital, Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
Abivax Announces Update to Obefazimod Phase 2b Clinical Development Program in Moderately to Severely Active Crohn ’s Disease
PARIS, France, February 2, 2024, 8:30 a.m. CET– Abivax SA (Euronext Paris& Nasdaq: ABVX) (“Abivax” or the“Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 2, 2024 Category: Pharmaceuticals Source Type: clinical trials
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Conditions: Crohn ' s Disease Interventions: Drug: TAK-279; Drug: Placebo Sponsors: Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Conditions: Crohn ' s Disease Interventions: Drug: Vedolizumab; Drug: Upadacitinib; Drug: Placebo Sponsors: Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
